MYBL2 mRNA expression as a potential biomarker of therapeutic response to genotoxic treatments in myelodysplastic syndrome

Oncotarget. 2018 Dec 25;9(101):37460-37461. doi: 10.18632/oncotarget.26477.
No abstract available

Keywords: DNA repair; MDS; aging; blood disorders; stem cells.

Publication types

  • Editorial